Nasopharyngeal carcinoma in Japan--clinical evaluation of EBV serology and EBV-associated nuclear antigens test.

[1]  W. Henle,et al.  Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to ebv serology , 1978, International journal of cancer.

[2]  G. de‐Thé,et al.  EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells , 1977, International journal of cancer.

[3]  M. Hsu,et al.  Prognosis of nasopharyngeal carcinoma by Epstein-Barr virus antibody titer. , 1977, Archives of otolaryngology.

[4]  M. Ng,et al.  Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. , 1976, British Journal of Cancer.

[5]  W. Henle,et al.  Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma , 1976, International journal of cancer.

[6]  T. Lindahl,et al.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Henle,et al.  Demonstration of epstein‐barr virus‐associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies , 1974, International journal of cancer.

[8]  U. Prasad.  Cells of origin of nasopharyngeal carcinoma: an electron microscopic study , 1974, The Journal of Laryngology & Otology.

[9]  W. Henle,et al.  False negative and prozone reactions in tests for antibodies to Epstein‐Barr virus‐associated nuclear antigen , 1974, International journal of cancer.

[10]  G. Klein,et al.  Relationship between Epstein‐Barr virus (EBV) DNA and the EBV‐determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies , 1974, International journal of cancer.

[11]  J. Chiou,et al.  Further studies on antibodies to early antigens induced by Epstein-Barr virus in nasopharyngeal carcinoma patients. , 1973, Gan.

[12]  H. Hausen,et al.  EB viral genomes in epithelial nasopharyngeal carcinoma cells. , 1973, Nature: New biology.

[13]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[14]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.

[15]  R. Thompson,et al.  Quantitation of exocrine IgA in human serum in health and disease. , 1970, Clinical and experimental immunology.

[16]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[17]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. , 1970, Journal of the National Cancer Institute.

[18]  Y. Hinuma,et al.  High incidence of Japanese infants with antibody to a herpes-type virus associated with cultured Burkitt lymphoma cells. , 1969, Japanese journal of microbiology.

[19]  Y. Hinuma,et al.  Cloning of Immunoglobulin-Producing Human Leukemic and Lymphoma Cells in Long-Term Cultures.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.